Heritable variation at the chromosome 21 gene ERG is associated with acute lymphoblastic leukemia risk in children with and without Down syndrome

Adam J. de Smith, Kyle M. Walsh, Libby M. Morimoto, Stephen S. Francis, Helen M. Hansen, Soyoung Jeon, Semira Gonseth, Minhui Chen, Hanxiao Sun, Sandra Luna-Fineman, Federico Antillón, Verónica Girón, Alice Y. Kang, Ivan Smirnov, Xiaorong Shao, Todd P. Whitehead, Lisa F. Barcellos, Kent W. Jolly, Jasmine Healy, Caroline LaverdièreDaniel Sinnett, Jeffrey W. Taub, Jillian M. Birch, Pamela D. Thompson, Maria S. Pombo-de-Oliveira, Logan G. Spector, Andrew T. DeWan, Beth A. Mueller, Charleston Chiang, Catherine Metayer, Xiaomei Ma, Joseph L. Wiemels

Research output: Contribution to journalLetterpeer-review

5 Scopus citations
Original languageEnglish (US)
Pages (from-to)2746-2751
Number of pages6
JournalLeukemia
Volume33
Issue number11
DOIs
StatePublished - Nov 1 2019

Bibliographical note

Funding Information:
Funding This study was supported by Alex’s Lemonade Stand Foundation “A” Awards (A.J.D., K.M.W.), the Emerging Investigator Fellowship Grant from the Pediatric Cancer Research Foundation (A.J.D.), The Children’s Health and Discovery Initiative of Translating Duke Health (K.M.W.), and research grants from the National Institutes of Health (R01 CA155461 to J.L.W. and X.M., R01 ES009137 to C.M., P24ES004705 to C.M., R24ES028524 to C.M. and L.M., and R21 ES021819 to L.M.). The 2016–2019 CLIC Scientific Annual Meetings were supported by the National Institute of Environmental Health Sciences of the National Institutes of Health under Award Number U13ES026496. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The collection of cancer incidence data used in the CCRLP study was supported by the California Department of Public Health pursuant to California Health and Safety Code Section 103885; Centers for Disease Control and Prevention’s (CDC) National Program of Cancer Registries, under cooperative agreement 5NU58DP003862–04/DP003862; the National Cancer Institute’s Surveillance, Epidemiology and End Results Program under contract HHSN261201000140C awarded to the Cancer Prevention Institute of California, contract HHSN261201000035C awarded to the University of Southern California, and contract HHSN261201000034C awarded to the Public Health Institute.

Cite this